TY  - JOUR
AU  - Mayén, Ana-Lucia
AU  - Aglago, Elom K
AU  - Knaze, Viktoria
AU  - Cordova, Reynalda
AU  - Schalkwijk, Casper G
AU  - Wagner, Karl-Heinz
AU  - Aleksandrova, Krasimira
AU  - Fedirko, Veronika
AU  - Keski-Rahkonen, Pekka
AU  - Leitzmann, Michael F
AU  - Katzke, Verena
AU  - Srour, Bernard
AU  - Schulze, Matthias B
AU  - Masala, Giovanna
AU  - Krogh, Vittorio
AU  - Panico, Salvatore
AU  - Tumino, Rosario
AU  - Bueno-de-Mesquita, Bas
AU  - Brustad, Magritt
AU  - Agudo, Antonio
AU  - Chirlaque López, María Dolores
AU  - Amiano, Pilar
AU  - Ohlsson, Bodil
AU  - Ramne, Stina
AU  - Aune, Dagfinn
AU  - Weiderpass, Elisabete
AU  - Jenab, Mazda
AU  - Freisling, Heinz
TI  - Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort study.
JO  - International journal of cancer
VL  - 149
IS  - 4
SN  - 0020-7136
CY  - Bognor Regis
PB  - Wiley-Liss
M1  - DKFZ-2021-01098
SP  - 854-864
PY  - 2021
N1  - 2021 Apr 25;149(4):854-864
AB  - Advanced glycation endproducts (AGEs) may contribute to liver carcinogenesis because of their proinflammatory and prooxidative properties. Diet is a major source of AGEs, but there is sparse human evidence on the role of AGEs intake in liver cancer etiology. We examined the association between dietary AGEs and the risk of hepatobiliary cancers in the European Prospective Investigation into Cancer and Nutrition prospective cohort (n = 450 111). Dietary intake of three AGEs, Nε -[carboxymethyl]lysine (CML), Nε -[1-carboxyethyl]lysine (CEL) and Nδ -[5-hydro-5-methyl-4-imidazolon-2-yl]-ornithine (MG-H1), was estimated using country-specific dietary questionnaires linked to an AGEs database. Cause-specific hazard ratios (HR) and their 95
KW  - EPIC study (Other)
KW  - advanced glycation endproducts (Other)
KW  - bile duct cancers (Other)
KW  - gallbladder cancer (Other)
KW  - hepatocellular carcinoma (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:33899229
DO  - DOI:10.1002/ijc.33612
UR  - https://inrepo02.dkfz.de/record/168847
ER  -